RxDoctor Payments Data

Kahyun Yoon-Flannery

Surgery · Hammonton, NJNPI 1871889386

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $40,750 of the $53,039 with a category attached, or 76.8%. Dilon Technologies, Inc. accounts for 94.2% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $44,456, more than ten times the $271 reported in 2019. Among surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,039in general payments, 2019–2025

Across 94 payments — averaging $564.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dilon Technologies, Inc.$50K
  • Biom'up France SAS$889
  • Stryker$591
  • Elucent Medical$339
  • Merit Medical Systems Inc$225
  • Biom'up SA$213
  • plus $827 from 12 others

What the payments were for

  • Consulting fees$40,75077%
  • Speaking & faculty fees$7001%
  • Travel & lodging$3,6287%
  • Food & beverage$7,96115%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,039 in reported general payments places this provider in the 95th percentile of 593 surgery providers in New Jersey.

See all surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$66,459
Medicare patients
164
Services billed
315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Hammonton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →